| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97f5e0717c4e0eae3a9b69eb22747bcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_990a52f35ea4f86a9fcdf45c7474cfee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98510a9ad48bc9b98e49491b39c425bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_905faad24d23d906de04627c47868bc0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate |
1993-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2b37fd4da8da5b524fe89b7ace8bd48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_398d80386b9f78d7b8746bbb6e0c1e88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba7a66556e3d87a17c856db5fa3153f |
| publicationDate |
1994-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9403633-A1 |
| titleOfInvention |
Assessment of trans-acting factors allelic variation |
| abstract |
The present invention provides a genetic test for assaying predisposition to and/or resistance to high rates of bone turnover, development of low bone mass and responsiveness or otherwise to therapeutic modalities. This is a specific model for use in prediction of osteoporosis and likely response to preventive or therapeutic modalities. It is a general model of allelic variation in transcriptional regulators determining physiological set-points and thus susceptibility or resistance to certain pathophysiological states. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9856908-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0015840-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10103308-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6558905-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5834200-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9727321-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9740187-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7354712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-733426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5998137-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6803197-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020092865-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0015839-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1394273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9728280-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9732998-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6808881-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0056922-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0056922-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-723751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9732998-A3 |
| priorityDate |
1992-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |